Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints... see more

NDAQ:APHA - Post Discussion

Aphria Inc. > BRIEF-Aphria Reports Q1 Loss Per Share Of $0.02
View:
Post by Mt69sinai on Oct 15, 2020 8:45am

BRIEF-Aphria Reports Q1 Loss Per Share Of $0.02

BRIEF-Aphria Reports Q1 Loss Per Share Of $0.02 

Reuters - Updated just now

Oct 15 (Reuters) - Aphria Inc:

* . ANNOUNCES RECORD ADULT-USE CANNABIS GROSS REVENUE IN FIRST QUARTER FISCAL YEAR 2021 AND SIXTH CONSECUTIVE QUARTER OF POSITIVE ADJUSTED EBITDA

* QTRLY NET CANNABIS REVENUE INCREASED 103% FROM PRIOR YEAR QUARTER

* QTRLY NET REVENUE OF $145.7 MILLION IN Q1, AN INCREASE OF 16% FROM PRIOR YEAR QUARTER

* QTRLY NET CANNABIS REVENUE OF $62.5 MILLION IN Q1, AN INCREASE OF 103% FROM PRIOR YEAR QUARTER

* AVERAGE RETAIL SELLING PRICE OF MEDICAL CANNABIS, BEFORE EXCISE TAX, INCREASED TO $7.38 PER GRAM IN QUARTER

* QTRLY LOSS PER SHARE $0.02

* Q1 REVENUE VIEW C$159.7 MILLION -- REFINITIV IBES DATA

* Q1 EARNINGS PER SHARE VIEW C$-0.04 -- REFINITIV IBES DATA Source text for Eikon: Further company coverage:

$$$$APHA$$$$

Comment by Sneekyboots on Oct 15, 2020 9:16am
Told you.......SneekyBoots 
Comment by aspen865 on Oct 15, 2020 9:27am
This post has been removed in accordance with Community Policy
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities